Cargando…

Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein

The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is the major target for antibody therapeutics. Shark-derived variable domains of new antigen receptors (VNARs) are the smallest antibody fragments with flexible paratopes that can recognize protein motifs inaccessible to classical ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-Lei, Lin, Jin-Jin, Ma, Huan, Zhong, Ning, Xie, Xin-Xin, Yang, Yunru, Zheng, Peiyi, Zhang, Ling-Jing, Jin, Tengchuan, Cao, Min-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502636/ https://www.ncbi.nlm.nih.gov/pubmed/36142819 http://dx.doi.org/10.3390/ijms231810904

Ejemplares similares

Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2
por: Cabanillas-Bernal, Olivia, et al.
Publicado: (2023)

The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles
por: Fernández-Quintero, Monica L., et al.
Publicado: (2022)

Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3
por: Cabanillas-Bernal, Olivia, et al.
Publicado: (2019)

Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody
por: Cheong, Wei Shien, et al.
Publicado: (2020)

3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection
por: Cong, Mengqing, et al.
Publicado: (2022)

In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development
por: Steven, John, et al.
Publicado: (2017)

Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis
por: Kovaleva, Marina, et al.
Publicado: (2017)

Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (Chiloscyllium plagiosum)
por: Jiang, Xierui, et al.
Publicado: (2023)

Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
por: Ma, Huan, et al.
Publicado: (2021)

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
por: Han, Pengcheng, et al.
Publicado: (2022)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
por: Zhao, Zhennan, et al.
Publicado: (2022)

Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins
por: Yu, Chuandi, et al.
Publicado: (2022)

A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
por: Wang, Xiaoning, et al.
Publicado: (2021)

Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
por: Valdovino-Navarro, Blanca J., et al.
Publicado: (2022)

Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development
por: Zhou, Yuchen, et al.
Publicado: (2023)

Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
por: Ma, Huan, et al.
Publicado: (2022)

Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike
por: Li, Yajuan, et al.
Publicado: (2022)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern
por: Kim, Seonghan, et al.
Publicado: (2022)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells
por: De March, Matteo, et al.
Publicado: (2022)

Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
por: Passariello, Margherita, et al.
Publicado: (2021)

SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells
por: Miao, Lu, et al.
Publicado: (2023)

Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein
por: Vetráková, A., et al.
Publicado: (2023)

Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern
por: Kim, Seonghan, et al.
Publicado: (2021)

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
por: Cao, Wenpeng, et al.
Publicado: (2021)

Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA
por: Zeng, Weihong, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
por: Voss, William N., et al.
Publicado: (2021)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR
por: Pothin, Elodie, et al.
Publicado: (2020)

VNAR development through antigen immunization of Japanese topeshark (Hemitriakis japanica)
por: Takeda, Hiroyuki, et al.
Publicado: (2023)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

Comparative structural analyses of selected spike protein-RBD mutations in SARS-CoV-2 lineages
por: Roy, Urmi
Publicado: (2021)

Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
por: da Costa, Clauber Henrique Souza, et al.
Publicado: (2022)

Improved Expression of SARS-CoV-2 Spike RBD Using the Insect Cell-Baculovirus System
por: Poodts, Joaquín, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f43nj0udt67pqj1cdlhbvv9tdh